Data protection Impressum

Financing

Geneva's AMP IT has raised new funding to bring total investment to EUR 7 million and expand its private EV charging platform across Switzerland and Europe.

AMP IT raises new funding to scale EV charging across Europe

18 May 2026

Chavannes-based PAVE Space has won the 2026 PERL Trophy for its kickstage orbital vehicle, which delivers satellites to their final orbit in under 24 hours.

PAVE Space wins the 2026 PERL Trophy for orbital innovation

11 May 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2026)

29 April 2026

Three Geneva-based start-ups have received seed funding through the FONGIT Innovation Fund (FIF), supporting innovations in olfactory diagnostics, AI-powered maritime chartering, and SME cybersecurity.

Geneva backs three start-ups tackling smell, shipping, and cyber threats

27 April 2026

Ecublens-based Daphne Technology has closed the first tranche of its current funding round with a CHF 15 million investment led by London-based sustainability investor Taranis, to accelerate the commercialization of its SlipPure methane abatement system for natural gas engines.

Daphne Technology raises CHF 15 million to scale its methane abatement system

21 April 2026

Geneva-based fermentation company Planetary has closed a CHF 16 million Series A equity round supplemented by CHF 6 million in credit, bringing total funding raised to approximately CHF 32 million, to expand its global technology licensing platform and consumer product rollout.

Planetary raises CHF 22 million to scale fermentation technology globally

21 April 2026

Four early-stage projects from the canton of Vaud have each received a CHF 10,000 FIT Impact grant, supporting low-tech, high-impact innovations in medical education, speech therapy, science outreach, and biodiversity monitoring.

FIT Impact grants awarded to four Vaud-based low-tech innovation projects

21 April 2026

ONWARD Medical has secured EUR 40.6 million through an accelerated bookbuild offering led by a EUR 25 million investment from EQT Life Sciences, extending the company's cash runway into the first quarter of 2028.

ONWARD Medical raises EUR 40 million to extend ARC therapy commercialization

20 April 2026

Lausanne-based AC Immune has amended its license and collaboration agreement with Eli Lilly to advance new Tau Morphomer small molecule candidates for Alzheimer's disease and other neurodegenerative diseases, with IND-enabling studies set to commence in the first half of 2026.

AC Immune secures CHF 10 million from Lilly to advance Alzheimer’s therapy

15 April 2026

Youdera, a one-stop clean energy partner for commercial and industrial customers, has secured a strategic investment from Amundi Energy Transition to support a EUR 150 million deployment plan in distributed energy infrastructure across Europe.

Youdera raises Amundi investment for EUR 150 million clean energy plan

14 April 2026

1 2 3 4 5 … 29